A股異動丨聆達股份(300125.SZ)大跌近10% 實控人涉嫌內幕交易遭證監會立案
格隆匯1月18日丨聆達股份(300125.SZ)低開低走,現跌幅擴大至近10%,低見12.57元創約一年半新低,總市值36億元。聆達股份今早公吿,收到公司實際控制人王正育先生轉發的中國證券監督管理委員會《立案吿知書》,因王正育先生涉嫌內幕交易“聆達股份”等違法違規,根據《中華人民共和國證券法》《中華人民共和國行政處罰法》等法律法規,中國證監會決定對其立案。本次立案調查系對王正育先生個人的調查,不會對公司正常生產經營活動產生重大影響。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.